IT1239283B - Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare. - Google Patents

Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.

Info

Publication number
IT1239283B
IT1239283B IT22312A IT2231289A IT1239283B IT 1239283 B IT1239283 B IT 1239283B IT 22312 A IT22312 A IT 22312A IT 2231289 A IT2231289 A IT 2231289A IT 1239283 B IT1239283 B IT 1239283B
Authority
IT
Italy
Prior art keywords
prevention
treatment
agent alone
ventricular arrhythmia
antiarrhythmic drug
Prior art date
Application number
IT22312A
Other languages
English (en)
Other versions
IT8922312A0 (it
IT8922312A1 (it
Inventor
Mauro Grossoni
Patrizia Salvati
Giorgio Ukmar
Lorenzo Vaga
Carlo Patrono
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Priority to IT22312A priority Critical patent/IT1239283B/it
Publication of IT8922312A0 publication Critical patent/IT8922312A0/it
Priority to JP2299683A priority patent/JPH03169826A/ja
Priority to DE4035226A priority patent/DE4035226A1/de
Publication of IT8922312A1 publication Critical patent/IT8922312A1/it
Application granted granted Critical
Publication of IT1239283B publication Critical patent/IT1239283B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT22312A 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare. IT1239283B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT22312A IT1239283B (it) 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.
JP2299683A JPH03169826A (ja) 1989-11-08 1990-11-05 心室不整脈の予防及び治療のためのムスカリン作用薬の使用
DE4035226A DE4035226A1 (de) 1989-11-08 1990-11-06 Verwendung eines als muscarinagonist wirkenden mittels zur praevention und behandlung ventrikulaerer arrhytmie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22312A IT1239283B (it) 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.

Publications (3)

Publication Number Publication Date
IT8922312A0 IT8922312A0 (it) 1989-11-08
IT8922312A1 IT8922312A1 (it) 1991-05-08
IT1239283B true IT1239283B (it) 1993-10-19

Family

ID=11194522

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22312A IT1239283B (it) 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.

Country Status (3)

Country Link
JP (1) JPH03169826A (it)
DE (1) DE4035226A1 (it)
IT (1) IT1239283B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2148999C1 (ru) * 1997-05-28 2000-05-20 Санкт-Петербургская государственная медицинская академия Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс
PE20180252A1 (es) * 2015-06-09 2018-02-02 Bayer Pharma AG Moduladores alostericos positivos del receptor muscarinico m2
MA63539A1 (fr) * 2023-12-25 2025-06-30 Université Mohammed V Rabat Pilocarpine dans le traitement des dysrégulations autonomiques à type de déficience vagale (hypertension artérielle et tachycardie dysautonomiques symptomatiques)

Also Published As

Publication number Publication date
IT8922312A0 (it) 1989-11-08
JPH03169826A (ja) 1991-07-23
DE4035226A1 (de) 1991-05-16
IT8922312A1 (it) 1991-05-08

Similar Documents

Publication Publication Date Title
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
IT1229195B (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
IT8423086A0 (it) Composizione farmaceutica o dietetica ad elevata attivita'antitrombotica e antiarteriosclerotica.
EP0331620A3 (en) Agent for the treatment of parkinson's disease
Kaminsky Aspects of harmony, rhythm and form in Schumann's Papillons, Carnaval and Davidsbündlertänze
OA09194A (en) "Insecticidal treatment and compositions therefor".
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
IT1239283B (it) Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
IT9047551A0 (it) Impiego di a-amminofluorochetoni per la preparazione di medicamenti ad attivita' cardiovascolare e antipertensiva.
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
DE69011356D1 (de) 6'Deoxy-6'-halogenoneplanosin A und dessen Herstellung.
IT8421046A0 (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия
IT8922398A0 (it) Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
IT8822256A0 (it) Associazione farmaceutica ad attivita' antitrombotica
EP0596359A3 (de) Fluorierte 1,3-Benzo- und 1,3-Pyrido-dioxole, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Pflanzenschutzmitteln.
RU97108900A (ru) Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс
IT8820571A0 (it) Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica, sua preparazione e relative composizioni farmaceutiche.
IT8521622A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10triacetossi-1,8,9 antracene.

Legal Events

Date Code Title Description
0001 Granted